7+ years of experience in Regulatory Affairs within biopharmaceutical industry
Deep understanding of EU regulatory requirements
Demonstrated experience engaging successfully with EMA
Expertise preferred in biologics, particularly monoclonal antibodies and rare diseases
Strong leadership and team management skills
Excellent written and verbal communication skills
Responsibilities
Define and implement global regulatory strategy to enhance success
Provide strategic input on assigned clinical and pipeline programs
Lead global supplemental/type 2 variation filing for OPAL
Develop regulatory roadmap and comprehensive engagement plan
Manage regulatory interactions and build relationships with authorities
Ensure timely submission of key regulatory documents
Monitor global regulatory landscape and ensure compliance
Benefits
Collaborative and inclusive work environment
Potential for professional growth and leadership development
Opportunity to work at the forefront of innovative biopharmaceutical therapies
Access to cutting-edge research and proprietary platform
Support for travel needs, both domestic and international
Full Job Description
Summary of Position:
The Director or Senior Director, Regulatory Strategy, reporting to the SVP, Global Head of Regulatory Affairs, is responsible for the development and implementation of the Global Strategy for assigned clinical and/or pipeline programs globally depending on the program. As a subject matter expert, this individual will represent regulatory affairs at the appropriate program team, highlighting risks and opportunities to inform program strategy and plan. The successful candidate will lead interactions with the regulatory authorities, directing the preparation and submission of regulatory submissions and correspondence.
Position Responsibilities
Serve as a thought leader on regulatory affairs, defining global regulatory strategy and plan to maximize regulatory success.
Serve as the global regulatory lead, providing strategic and operational input on assigned clinical and/or pipeline programs, such as the subcutaneous (IV to SC) and OPAL (
Be responsible for leading the global supplemental/type 2 variation filing lead for OPAL (
Develop regulatory roadmap to inform and guide agency engagement strategy; partner with key stakeholders to develop and implement a comprehensive regulatory engagement plan
Lead and managing regulatory interactions on assigned programs, building trusted relationships with regulatory authorities
Lead cross-functional effort to ensure timely submission of key regulatory documents (e.g., Module 1, briefing documents)
Ensure program team members and cross-functional stakeholders are informed of internal and external events that may impact regulatory success
Identify regulatory risks and opportunities and work with key stakeholders to develop solutions
Partner with global market access and medical affairs colleagues to support interactions with joint regulatory/health agency/HTA bodies on product specific value evidence topics, as applicable
Partner with Global and local Marketing/ Commercial as needed to align Regulatory Plan and Marketing/Commercial plan
Ensure strong representation of regulatory voice at key governance bodies and teams (e.g., DRC, program teams, clinical development teams, study teams)
Maintain currency of regulatory requirements and approvals to inform regulatory strategies and drive proactive plans to ensure compliance
Monitor and analyze global and country specific regulatory landscape to assess potential impact on the program; collaborate with teams to ensure compliance
Provide support to local regulatory experts
Provide regulatory support for cross-functional activities (e.g., SOPs, business development, clinical labeling, disclosure) as needed
Candidate Requirements
Education in life sciences required
Greater Boston-based with ability to be regularly present in the Cambridge, MA office
7+ years of experience Regulatory Affairs in biopharmaceutical industry with deep understanding of EU regulatory requirements
Demonstrated experience of leading successful engagement with EMA
Expertise and experience with biologics (particularly monoclonal antibody therapeutics) and rare diseases strongly preferred but not required
Demonstrated reputation as a well-respected, dynamic team leader with strong leadership and people management skills
Strong written, verbal communication skills, and interpersonal skills
Capable of managing shifting priorities in a rapidly changing and environment
Ability to travel domestically and internationally (~10%)
$200,000 - $300,000 a year
About Scholar Rock Holding Corporation
Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company that focuses on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company's proprietary platform technology is based on the use of growth factor-binding proteins to selectively inhibit the activation of these signaling pathways in a variety of tissues. Scholar Rock's lead product candidate, SRK-015, is a highly specific inhibitor of the activation of the growth factor myostatin, which is involved in the regulation of muscle mass. The company is headquartered in Cambridge, Massachusetts and was founded in 2012.